Spotlighting the Invetech and General Fluidics collaboration: Robert Granier (CEO, General Fluidics) joins Andreas Knaack (CEO & President, Invetech) to discuss their partnership and what makes a successful development collaboration.
Invetech works with diagnostics and cell and gene therapy companies in their quest to bring novel IVD devices and life-saving therapies to market from early feasibility through scale manufacturing and lifecycle support. One integrated team, one point of accountability, at every stage. General Fluidics is a Boston-based diagnostic company that spun out of Massachusetts General Hospital in 2018. The company is focused on making diagnostic testing more accessible for all patients.
